Brendan T Keenan1, Jinyoung Kim1,2, Bhajan Singh3, Lia Bittencourt4, Ning-Hung Chen5, Peter A Cistulli6, Ulysses J Magalang7, Nigel McArdle3, Jesse W Mindel7, Bryndis Benediktsdottir8,9, Erna Sif Arnardottir8,9, Lisa Kristin Prochnow10, Thomas Penzel10, Bernd Sanner11, Richard J Schwab1, Chol Shin12, Kate Sutherland6, Sergio Tufik4, Greg Maislin1, Thorarinn Gislason8,9, Allan I Pack1. 1. Center for Sleep and Circadian Neurobiology, University of Pennsylvania, Philadelphia, PA. 2. School of Nursing, University of Pennsylvania, Philadelphia, PA. 3. Sir Charles Gairdner Hospital, Western Australian Sleep Disorders Research Institute, Nedlands, Western Australia, Australia. 4. Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil. 5. Division of Pulmonary, Critical Care, and Sleep Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan. 6. Royal North Shore Hospital, Northern Clinical School, and Charles Perkins Centre University of Sydney, Australia. 7. Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH. 8. Department of Sleep, Landspitali University Hospital, Reykjavik, Iceland. 9. Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 10. Interdisciplinary Center of Sleep Medicine, Charité University Hospital, Berlin, Germany. 11. Department of Pulmonary Medicine, Agaplesion Bethesda Krankenhaus Wuppertal, Wuppertal, Germany. 12. Pulmonary, Critical Care and Sleep Disorder Center, Korea University Medical Center Ansan Hospital, Seoul, South Korea.
Abstract
Study Objectives: A recent study of patients with moderate-severe obstructive sleep apnea (OSA) in Iceland identified three clinical clusters based on symptoms and comorbidities. We sought to verify this finding in a new cohort in Iceland and examine the generalizability of OSA clusters in an international ethnically diverse cohort. Methods: Using data on 972 patients with moderate-severe OSA (apnea-hypopnea index [AHI] ≥ 15 events per hour) recruited from the Sleep Apnea Global Interdisciplinary Consortium (SAGIC), we performed a latent class analysis of 18 self-reported symptom variables, hypertension, cardiovascular disease, and diabetes. Results: The original OSA clusters of disturbed sleep, minimally symptomatic, and excessively sleepy replicated among 215 SAGIC patients from Iceland. These clusters also generalized to 757 patients from five other countries. The three clusters had similar average AHI values in both Iceland and the international samples, suggesting clusters are not driven by OSA severity; differences in age, gender, and body mass index were also generally small. Within the international sample, the three original clusters were expanded to five optimal clusters: three were similar to those in Iceland (labeled disturbed sleep, minimal symptoms, and upper airway symptoms with sleepiness) and two were new, less symptomatic clusters (labeled upper airway symptoms dominant and sleepiness dominant). The five clusters showed differences in demographics and AHI, although all were middle-aged (44.6-54.5 years), obese (30.6-35.9 kg/m2), and had severe OSA (42.0-51.4 events per hour) on average. Conclusions: Results confirm and extend previously identified clinical clusters in OSA. These clusters provide an opportunity for a more personalized approach to the management of OSA.
Study Objectives: A recent study of patients with moderate-severe obstructive sleep apnea (OSA) in Iceland identified three clinical clusters based on symptoms and comorbidities. We sought to verify this finding in a new cohort in Iceland and examine the generalizability of OSA clusters in an international ethnically diverse cohort. Methods: Using data on 972 patients with moderate-severe OSA (apnea-hypopnea index [AHI] ≥ 15 events per hour) recruited from the Sleep Apnea Global Interdisciplinary Consortium (SAGIC), we performed a latent class analysis of 18 self-reported symptom variables, hypertension, cardiovascular disease, and diabetes. Results: The original OSA clusters of disturbed sleep, minimally symptomatic, and excessively sleepy replicated among 215 SAGIC patients from Iceland. These clusters also generalized to 757 patients from five other countries. The three clusters had similar average AHI values in both Iceland and the international samples, suggesting clusters are not driven by OSA severity; differences in age, gender, and body mass index were also generally small. Within the international sample, the three original clusters were expanded to five optimal clusters: three were similar to those in Iceland (labeled disturbed sleep, minimal symptoms, and upper airway symptoms with sleepiness) and two were new, less symptomatic clusters (labeled upper airway symptoms dominant and sleepiness dominant). The five clusters showed differences in demographics and AHI, although all were middle-aged (44.6-54.5 years), obese (30.6-35.9 kg/m2), and had severe OSA (42.0-51.4 events per hour) on average. Conclusions: Results confirm and extend previously identified clinical clusters in OSA. These clusters provide an opportunity for a more personalized approach to the management of OSA.
Authors: Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi Journal: Am J Respir Crit Care Med Date: 2010-03-25 Impact factor: 21.405
Authors: Luciano F Drager; Luiz A Bortolotto; Maria Cecília Lorenzi; Adelaide C Figueiredo; Eduardo M Krieger; Geraldo Lorenzi-Filho Journal: Am J Respir Crit Care Med Date: 2005-05-18 Impact factor: 21.405
Authors: Erla Björnsdóttir; Christer Janson; Jón F Sigurdsson; Philip Gehrman; Michael Perlis; Sigurdur Juliusson; Erna S Arnardottir; Samuel T Kuna; Allan I Pack; Thorarinn Gislason; Bryndis Benediktsdóttir Journal: Sleep Date: 2013-12-01 Impact factor: 5.849
Authors: Tarja Saaresranta; Jan Hedner; Maria R Bonsignore; Renata L Riha; Walter T McNicholas; Thomas Penzel; Ulla Anttalainen; John Arthur Kvamme; Martin Pretl; Pawel Sliwinski; Johan Verbraecken; Ludger Grote Journal: PLoS One Date: 2016-10-04 Impact factor: 3.240
Authors: Diego R Mazzotti; Diane C Lim; Kate Sutherland; Lia Bittencourt; Jesse W Mindel; Ulysses Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel Journal: Physiol Meas Date: 2018-09-13 Impact factor: 2.833
Authors: Sonja G Schütz; Lynda D Lisabeth; Fatema Shafie-Khorassani; Erin Case; Brisa N Sanchez; Ronald D Chervin; Devin L Brown Journal: Sleep Med Date: 2019-04-15 Impact factor: 3.492
Authors: Patricia Peñacoba; M Antònia Llauger; Ana M Fortuna; Xavier Flor; Gabriel Sampol; Anna Maria Pedro Pijoan; Núria Grau; Carme Santiveri; Joan Juvanteny; José Ignacio Aoiz; Joan Bayó; Patricia Lloberes; Mercè Mayos Journal: J Clin Sleep Med Date: 2020-09-15 Impact factor: 4.062
Authors: Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel Journal: Sleep Med Rev Date: 2020-03-20 Impact factor: 11.609